ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,635Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1692

$1.42M Total Retail Price of All Prescriptions

Rank: 13 out of 1692

1,211 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 1,211 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 1,211 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 18,057 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,437 839 S3 1 6
LEVOTHYROXINE SODIUM 905 681 2 4
LISINOPRIL 886 662 3 2
OMEPRAZOLE 765 612 4 5
AMLODIPINE BESYLATE 761 603 5 3
SIMVASTATIN 698 502 6 1
FUROSEMIDE 693 497 7 7
METFORMIN HCL 648 455 8 8
METOPROLOL TARTRATE 602 513 9 10
HYDROCHLOROTHIAZIDE 533 391 10 9
ZOLPIDEM TARTRATE 480 305 11 23
PRAVASTATIN SODIUM 462 321 12 12
WARFARIN SODIUM 446 338 13 14
OXYCODONE HCL 432 162 S2 14 56
POTASSIUM CHLORIDE 419 276 15 20
CITALOPRAM HBR 361 233 16 21
GABAPENTIN 324 121 17 13
DONEPEZIL HCL 324 287 17 29
AZITHROMYCIN 317 224 19 34
RANITIDINE HCL 263 206 20 28
CARVEDILOL 258 221 21 24
SULFAMETHOXAZOLE-TRIMETHOPRIM 239 175 22 100
LISINOPRIL-HYDROCHLOROTHIAZIDE 236 185 23 19
ATORVASTATIN CALCIUM 236 166 23 11
NEXIUM 235 107 25 25
PANTOPRAZOLE SODIUM 233 162 26 39
ATENOLOL 215 160 27 15
TRAZODONE HCL 211 132 28 33
FLUOXETINE HCL 209 128 29 52
ADVAIR DISKUS 201 98 30 45
PREDNISONE 193 139 31 35
ALLOPURINOL 191 140 32 30
OXYCODONE HCL-ACETAMINOPHEN 185 75 S2 33 94
SPIRIVA 182 90 34 44
CLOPIDOGREL 180 143 35 43
LOSARTAN POTASSIUM 177 128 36 17
FLUTICASONE PROPIONATE 166 91 37 27
CYMBALTA 161 79 38 51
PROAIR HFA 156 97 39 40
TRAMADOL HCL 153 84 40 16
ISOSORBIDE MONONITRATE ER 150 140 41 55
ENALAPRIL MALEATE 150 130 41 71
PROMETHAZINE HCL 148 79 R 43 81
METOPROLOL SUCCINATE 148 133 43 18
CYCLOBENZAPRINE HCL 141 48 R 45 54
TAMSULOSIN HCL 140 105 46 31
RISPERIDONE 139 100 47 77
AMITRIPTYLINE HCL 136 103 R 48 58
CRESTOR 136 93 48 26
BENAZEPRIL HCL 136 118 48 69
GLIMEPIRIDE 132 105 51 32
KLOR-CON M20 130 80 52 48
SERTRALINE HCL 129 100 53 22
NAPROXEN 128 85 54 91
ALENDRONATE SODIUM 127 103 55 36
LANTUS 125 71 56 57
COMBIVENT 120 41 57 141
PLAVIX 119 95 58 66
DIOVAN 118 80 59 42
ALPRAZOLAM 116 108 60 188
LOVASTATIN 114 90 61 37
AMOXICILLIN 111 86 62 95
MELOXICAM 110 82 63 41
LANTUS SOLOSTAR 109 58 64 102
VENLAFAXINE HCL ER 108 66 65 84
RAMIPRIL 105 80 66 108
KLOR-CON M10 97 81 67 106
PHENYTOIN SODIUM EXTENDED 96 47 68 136
IBUPROFEN 96 46 68 78
GLIPIZIDE 91 78 70 47
FENTANYL 90 56 S2 71 88
QUETIAPINE FUMARATE 88 64 72 62
DICLOFENAC SODIUM 85 36 73 75
LYRICA 84 65 74 111
GEMFIBROZIL 83 53 75 98
FLUCONAZOLE 80 50 76 175
PRAMIPEXOLE DIHYDROCHLORIDE 79 40 77 216
VOLTAREN 76 56 78 238
ESCITALOPRAM OXALATE 72 46 79 76
MECLIZINE HCL 71 45 80 124
POLYETHYLENE GLYCOL 3350 70 45 81 64
PAROXETINE HCL 70 48 81 60
CARBIDOPA-LEVODOPA 69 57 83 110
LEVOFLOXACIN 68 38 84 113
MIRTAZAPINE 67 52 85 53
DILTIAZEM 24HR CD 66 54 86 96
SYNTHROID 66 56 86 59
ROPINIROLE HCL 65 35 88 101
QUINAPRIL HCL 63 43 89 147
KETOCONAZOLE 61 42 90 242
DIGOXIN 60 56 91 85
DILTIAZEM 24HR ER 60 59 91 134
SPIRONOLACTONE 59 42 93 74
CHLORTHALIDONE 58 53 94 143
NAMENDA 58 55 94 50
INSULIN SYRINGE 58 35 94 93
TRIAMTERENE-HCTZ 57 35 97 61
ZETIA 57 45 97 68
LOSARTAN-HYDROCHLOROTHIAZIDE 57 22 97 38
HYDROCORTISONE 57 43 97 261
DOXYCYCLINE HYCLATE 56 37 101 126
LANSOPRAZOLE 56 36 101 133
SINGULAIR 56 23 101 79
CLONIDINE HCL 56 15 101 46
BENAZEPRIL-HYDROCHLOROTHIAZIDE 56 38 101 177
LIPITOR 55 28 106 119
HYDROXYZINE HCL 53 46 R 107 182
GLYBURIDE 53 50 R 107 82
PROPRANOLOL HCL 52 37 109 109
BUSPIRONE HCL 51 16 110 122
VALACYCLOVIR 50 39 111 460
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.